Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

8.51
+0.01000.12%
Post-market: 8.510.00000.00%16:10 EST
Volume:4.85K
Turnover:41.47K
Market Cap:13.75M
PE:-0.30
High:8.74
Open:8.70
Low:8.50
Close:8.50
52wk High:41.80
52wk Low:5.01
Shares:1.62M
Float Shares:1.18M
Volume Ratio:0.15
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-28.3870
EPS(LYR):-66.9021
ROE:-651.40%
ROA:-99.47%
PB:-11.32
PE(LYR):-0.13

Loading ...

Quoin Pharmaceuticals highlights continued growth of NETHERTON NOW program

TIPRANKS
·
Yesterday

NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome

GlobeNewswire
·
Yesterday

Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause

TIPRANKS
·
Feb 17

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:11 AM

Reuters
·
Feb 17

Quoin Pharmaceuticals Files Initial Beneficial Ownership Statement for Stonepine Capital Management

Reuters
·
Feb 03

Quoin Pharmaceuticals Submits QRX003 for Orphan Drug Designation and Fast Track Review in Japan

Reuters
·
Jan 28

Quoin announces submission to Japanese MHLW for ODD for QRX003

TIPRANKS
·
Jan 27

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application for QRX003 in Saudi Arabia

Reuters
·
Jan 20

ADRs Close Lower; Quoin Pharmaceuticals Ltd. Declines 36%

Dow Jones
·
Dec 06, 2025

Top Premarket Decliners

MT Newswires Live
·
Dec 05, 2025

Quoin Pharmaceuticals Approves New Stock Option Agreements

TIPRANKS
·
Nov 18, 2025

Quoin Pharmaceuticals Unveils New Equity Incentive Plan for Executives and Directors

Reuters
·
Nov 18, 2025

Quoin Pharmaceuticals Achieves Key Milestone in Rapamycin Delivery

TIPRANKS
·
Nov 12, 2025

Quoin Pharmaceuticals Achieves Target Rapamycin Loadings in Topical Delivery Technologies

Reuters
·
Nov 11, 2025

Quoin Pharmaceuticals Ltd reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 06, 2025

Quoin Pharmaceuticals reports Q3 EPS ($6.71) vs. ($16.29) last year

TIPRANKS
·
Nov 06, 2025

Quoin Pharmaceuticals sees cash runway into 2027

TIPRANKS
·
Nov 06, 2025

Quoin Pharmaceuticals Q3 EPS $(6.71) Misses $(6.50) Estimate

Benzinga
·
Nov 06, 2025

Press Release: Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results

Dow Jones
·
Nov 06, 2025

Quoin Pharmaceuticals Ltd expected to post a loss of $4.98 a share - Earnings Preview

Reuters
·
Nov 04, 2025